logo
Search…
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Search...
search
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Home > Stocks > HK Stock

CSPC Pharma (01093) spent HK $29.8096 million to repurchase 6.44 million shares on September 17th.

date
16:54 17/09/2024
avatar
GMT Eight
Shiyao Group (01093) announced that the company spent HK$2980.96 million on September 17, 2024...
CSPC PHARMA (01093) announced that the company repurchased 6.44 million shares for a total of 29.8096 million Hong Kong dollars on September 17, 2024, with a buyback price of 4.58-4.66 Hong Kong dollars per share.
Related Articles
HK Stock Market Move | YOFC (06869) dropped nearly 15% after its performance results, with UBS indicating that its first-quarter profits were below market expectations. The rise in fiber optic prices may take some time to fully reflect.
US Stock
NVIDIA Corporation (NVDA.US) makes its first move into legal AI, betting on the $5.6 billion valuation startup Legora.
China Stock
Zhuzhou Qianjin Pharmaceutical (600479.SH): Progesterone soft capsule, Linagliptin tablets obtained drug registration certificate.
HK Stock Market Move | YOFC (06869) dropped nearly 15% after its performance results, with UBS indicating that its first-quarter profits were below market expectations. The rise in fiber optic prices may take some time to fully reflect.
NVIDIA Corporation (NVDA.US) makes its first move into legal AI, betting on the $5.6 billion valuation startup Legora.
US Stock
Zhuzhou Qianjin Pharmaceutical (600479.SH): Progesterone soft capsule, Linagliptin tablets obtained drug registration certificate.
China Stock
RECOMMEND
China Leads as Humanoid Robotics Reach Commercial Turning Point
China Leads as Humanoid Robotics Reach Commercial Turning Point
icon
29/04/2026
AI Disruption Reshapes US Equity Valuations as Terminal Value Volatility Takes Center Stage
AI Disruption Reshapes US Equity Valuations as Terminal Value Volatility Takes Center Stage
icon
29/04/2026
Political Bureau Meeting Sets Tone for Growth Eight Key Takeaways on Property Capital Markets and Monetary Policy
Political Bureau Meeting Sets Tone for Growth Eight Key Takeaways on Property Capital Markets and Monetary Policy
icon
29/04/2026
logo
Contact US
qr
+852 - 60190728
gmteight@futurecultural.com
Customer Support
About Us
Contact Us
Frequently Asked
Privacy Policy
Terms of Use
Commercial Services
Advertising
Business Development
Copyright
Terms of Service
©️2013 - 2026 GMT EIGHT Holdings. All Rights Reserved.